Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
J Immunol Res ; 2017: 3940743, 2017.
Article in English | MEDLINE | ID: mdl-28695135

ABSTRACT

Previously transgenic Kalanchoe pinnata plants producing an antimicrobial peptide cecropin P1 (CecP1) have been reported. Now we report biological testing K. pinnata extracts containing CecP1 as a candidate drug for treatment of wounds infected with Candida albicans. The drug constitutes the whole juice from K. pinnata leaves (not ethanol extract) sterilized with nanofiltration. A microbicide activity of CecP1 against an animal fungal pathogen in vivo was demonstrated for the first time. However, a favorable therapeutic effect of the transgenic K. pinnata extract was attributed to a synergism between the fungicide activity of CecP1 and wound healing (antiscar), revascularizing, and immunomodulating effect of natural biologically active components of K. pinnata. A commercial fungicide preparation clotrimazole eliminated C. albicans cells within infected wounds in rats with efficiency comparable to CecP1-enriched K. pinnata extract. But in contrast to K. pinnata extract, clotrimazole did not exhibit neither wound healing activity nor remodeling of the scar matrix. Taken together, our results allow assumption that CecP1-enriched K. pinnata extracts should be considered as a candidate drug for treatment of dermatomycoses, wounds infected with fungi, and bedsores.


Subject(s)
Candidiasis/drug therapy , Immunomodulation , Kalanchoe/chemistry , Peptides/therapeutic use , Plant Extracts/therapeutic use , Wound Healing/drug effects , Wound Infection/drug therapy , Animals , Antifungal Agents/administration & dosage , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Antifungal Agents/therapeutic use , Candida albicans/drug effects , Candidiasis/microbiology , Clotrimazole/therapeutic use , Dermatomycoses/drug therapy , Drug Synergism , Kalanchoe/genetics , Peptides/administration & dosage , Peptides/metabolism , Phytotherapy , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Rats
2.
J Immunol Res ; 2017: 4645701, 2017.
Article in English | MEDLINE | ID: mdl-28326334

ABSTRACT

Procedure of manufacturing K. pinnata water extracts containing cecropin P1 (CecP1) from the formerly described transgenic plants is established. It included incubation of leaves at +4°C for 7 days, mechanical homogenization of leaves using water as extraction solvent, and heating at +70°C for inactivating plant enzymes. Yield of CecP1 (after heating and sterilizing filtration) was 0.3% of total protein in the extract. The water extract of K. pinnata + CecP1 exhibits favorable effect on healing of wounds infected with S. aureus (equal to Cefazolin) and with a combination of S. aureus with P. aeruginosa (better than Cefazolin). Wild-type K. pinnata extract exhibited evident microbicide activity against S. aureus with P. aeruginosa but it was substantially strengthened in K. pinnata + CecP1 extract. K. pinnata extracts (both wild-type and transgenic) did not exhibit general toxicity and accelerated wound recovery. Due to immunomodulating activity, wild-type K. pinnata extract accelerated granulation of the wound bed and marginal epithelialization even better than K. pinnata + CecP1 extract. Immunomodulating and microbicide activity of K. pinnata synergizes with microbicide activity of CecP1 accelerating elimination of bacteria.


Subject(s)
Anti-Infective Agents/therapeutic use , Kalanchoe/genetics , Peptides/therapeutic use , Plant Extracts/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/physiology , Recombinant Proteins/therapeutic use , Staphylococcal Infections/drug therapy , Staphylococcus aureus/physiology , Wound Infection/drug therapy , Animals , Cefazolin/therapeutic use , Humans , Immunomodulation , Male , Peptides/genetics , Plants, Genetically Modified , Rats , Rats, Wistar , Recombinant Proteins/genetics , Swine , Wound Healing/drug effects
3.
Biochemistry (Mosc) ; 81(9): 968-71, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27682168

ABSTRACT

Transgenic kalanchoe plants (Kalanchoe pinnata L.) expressing the antimicrobial peptide cecropin P1 gene (cecP1) under the control of the 35S cauliflower mosaic virus 35S RNA promoter and the selective neomycin phosphotransferase II (nptII) gene under the control of the nopaline synthase gene promoter were studied. The 35S promoter methylation and the cecropin P1 biosynthesis levels were compared in plants growing on media with and without kanamycin. The low level of active 35S promoter methylation further decreases upon cultivation on kanamycin-containing medium, while cecropin P1 synthesis increases.


Subject(s)
DNA Methylation , DNA, Plant , Drug Resistance , Insect Proteins , Kalanchoe , Kanamycin , Plants, Genetically Modified , Promoter Regions, Genetic , Transgenes , DNA, Plant/genetics , DNA, Plant/metabolism , Insect Proteins/biosynthesis , Insect Proteins/genetics , Kalanchoe/genetics , Kalanchoe/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism
4.
Biochemistry (Mosc) ; 79(2): 77-87, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24794723

ABSTRACT

DNA methyltransferases might be used as powerful tools for studies in molecular and cell biology due to their ability to recognize and modify nitrogen bases in specific sequences of the genome. Methylation of the eukaryotic genome using exogenous DNA methyltransferases appears to be a promising approach for studies on chromatin structure. Currently, the development of new methods for targeted methylation of specific genetic loci using DNA methyltransferases fused with DNA-binding proteins is especially interesting. In the present review, expression of exogenous DNA methyltransferase for purposes of in vivo analysis of the functional chromatin structure along with investigation of the functional role of DNA methylation in cell processes are discussed, as well as future prospects for application of DNA methyltransferases in epigenetic therapy and in plant selection.


Subject(s)
Cytological Techniques/methods , DNA (Cytosine-5-)-Methyltransferases/genetics , Molecular Biology/methods , Animals , DNA (Cytosine-5-)-Methyltransferases/metabolism , Gene Expression , Humans
5.
Gene ; 157(1-2): 283-7, 1995 May 19.
Article in English | MEDLINE | ID: mdl-7607509

ABSTRACT

The EcoRII DNA methyltransferase (M-EcoRII; MTase) modifies a cytosine in the DNA sequence CCWGG which contains a CNG methylation motif characteristic of plant DNA. The gene (ecoRIIM) encoding this MTase has been cloned into the T-DNA of the wild-type Agrobacterium Ti-plasmid pTiC58 downstream from the plant expression nopaline synthase-encoding gene promoter. Nicotiana tabacum cells have been transformed with Agrobacterium tumefaciens harbouring this recombinant Ti-plasmid. The primary transformed tabacco tissue line has given rise to novel stable lines which are morphologically distinctive. Southern hybridization analysis of all transformed tissue lines has shown the presence, in each of them, of ecoRIIM. The tissue studied differed in morphology in callus culture, dependence on phytohormones and the ability to synthesize nopaline.


Subject(s)
DNA-Cytosine Methylases/biosynthesis , Nicotiana/growth & development , Plants, Toxic , Agrobacterium tumefaciens , Amino Acid Oxidoreductases/biosynthesis , Amino Acid Oxidoreductases/genetics , Base Sequence , DNA-Cytosine Methylases/genetics , Genetic Vectors , Methylation , Plants, Genetically Modified , Promoter Regions, Genetic , Recombinant Proteins/biosynthesis , Restriction Mapping , Substrate Specificity , Nicotiana/enzymology , Nicotiana/genetics
6.
Biochem Mol Biol Int ; 29(1): 113-21, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8490558

ABSTRACT

The binding of restriction endonuclease EcoRII to synthetic oligodeoxyribonucleotide substrates 11 to 30 bp long was investigated by gradient polyacrylamide gel electrophoresis under nondenaturing conditions in the absence of Mg2+ ions. Irrespective of the substrate's length, two types of specific DNA-protein complexes were shown to be formed. Their mobility in gel was close to that of the monomer and the dimer of the marker ovalbumin. The number of such complexes in solution depended on the ratio of the molar concentrations of restriction endonuclease EcoRII and the DNA duplex. The possible structure of the complexes is discussed.


Subject(s)
DNA/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Autoradiography , Base Sequence , Electrophoresis, Polyacrylamide Gel , Escherichia coli/enzymology , Molecular Sequence Data , Oligodeoxyribonucleotides/metabolism , Protein Binding
7.
Biochim Biophys Acta ; 1009(3): 290-2, 1989 Dec 22.
Article in English | MEDLINE | ID: mdl-2597679

ABSTRACT

The nucleotide sequence of a 1394 basepair (bp) DNA fragment containing the EcoRII restriction endonuclease (R.EcoRII) gene was determined. The endonuclease gene is 1206 bp in length (predicted 402 amino acids (aa) and Mr = 45 178) and is separated by 33 bp from the EcoRII modification methylase (M.EcoRII) gene. The EcoRII restriction-modification system has a tail-to-tail organization of the two genes.


Subject(s)
Deoxyribonucleases, Type II Site-Specific/genetics , Amino Acid Sequence , Base Sequence , DNA/genetics , Molecular Sequence Data
10.
Nucleic Acids Res ; 13(24): 8983-98, 1985 Dec 20.
Article in English | MEDLINE | ID: mdl-3001656

ABSTRACT

The present study deals with the binding and cleavage by EcoRII endonuclease of concatemer DNA duplexes containing EcoRII recognition sites (formula; see text) in which dT is replaced by dU or 5-bromodeoxyuridine, or 5'-terminal dC in the dT-containing strand is methylated at position 5. The enzyme molecule is found to interact with the methyl group of the dT residue of the DNA recognition site and to be at least in proximity to the H5 atom of the 5'-terminal dC residue in dT-containing strand of this site. Modification of any of these positions exerts an equal effects on the cleavage of both DNA strands. Endonuclease EcoRII was found to bind the substrate specifically. At the same time modification of the bases in recognized sequence may result in the formation of unproductive, though stable, enzyme-substrate complexes.


Subject(s)
DNA Restriction Enzymes/metabolism , DNA/metabolism , Deoxyribonucleases, Type II Site-Specific , Base Sequence , DNA-Binding Proteins/metabolism , Kinetics , Oligodeoxyribonucleotides/chemical synthesis , Oligodeoxyribonucleotides/metabolism , Protein Binding , Structure-Activity Relationship
11.
Eur J Biochem ; 150(2): 323-30, 1985 Jul 15.
Article in English | MEDLINE | ID: mdl-3894024

ABSTRACT

We have investigated the susceptibility of the genomes of the related bacteriophages T3 and T7 to the three major DNA methyltransferases (EcoK, dam, dcm) of their host, Escherichia coli K12. In vivo the EcoK host specificity enzyme only methylates the DNA of ocr- phages. This is due to an inhibition of the enzyme by the phage ocr+ gene product, which had previously been shown to be an inhibitor of the restriction endonuclease. EcoK-specific DNA methylation protects the ocr- viruses after one growth cycle on these host cells against the action of corresponding restriction endonuclease EcoK. Owing to the unique S-adenosyl-L-methionine hydrolase (sam+) activity of the T3-coded ocr+ protein, the T3 DNA is absolutely devoid of the methylated bases 6-methylaminopurine and 5-methylcytosine. In contrast to this, T7 derivatives and sam- derivatives of T3 carry a small number of about 2-4 molecules 6-methylaminopurine and 5-methylcytosine per genome. The presence of 6-methylaminopurine is due to dam methylation, though the majority of dam sites remain unmethylated. In vivo as well as in vitro the ocr+ protein has no influence on the activities of the dam and dcm methylase. The experiments gave some evidence for the existence of a second cytosine methylase in E. coli K12. Besides dam and dcm recognition sites being undermethylated, their absolute number in T3 and T7 DNAs is far below the expected value. Moreover, one of the two dcm sites present in T7 (Studier strain) is missing in our T7 strain owing to a 1300-base-pair deletion in gene 0.7.


Subject(s)
DNA (Cytosine-5-)-Methyltransferases/pharmacology , DNA, Viral/metabolism , Escherichia coli/enzymology , Methyltransferases/pharmacology , T-Phages/metabolism , 5-Methylcytosine , Adenine/analogs & derivatives , Adenine/analysis , Base Sequence , Binding Sites , Cytosine/analogs & derivatives , Cytosine/analysis , DNA, Viral/analysis , Genes, Viral , Phenotype , Transfection , Viral Proteins/pharmacology
12.
Mol Gen Genet ; 178(3): 717-8, 1980.
Article in English | MEDLINE | ID: mdl-6248737

ABSTRACT

The genes for restriction-modification system EcoRII have been cloned from plasmid N3 DNA using RSF2124 as a vector plasmid. The hybrid plasmids designated pFK321 and pFK322 contained a 5.8 megadaltons EcoRI--fragment derived from N3 DNA including the genes for restriction-modification system EcoRII and a gene for resistance to sulfanilamide.


Subject(s)
Cloning, Molecular , DNA Restriction Enzymes/genetics , Genes , Methyltransferases/genetics , Plasmids , Bacteriophage lambda/genetics , Escherichia coli/genetics , Genes, Viral , Sulfanilamides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...